Literature DB >> 24390438

Methylene blue microbubbles as a model dual-modality contrast agent for ultrasound and activatable photoacoustic imaging.

Mansik Jeon1, Wentao Song2, Elizabeth Huynh3, Jungho Kim4, Jeesu Kim1, Brandon L Helfield3, Ben Y C Leung5, David E Goertz6, Gang Zheng3, Jungtaek Oh4, Jonathan F Lovell2, Chulhong Kim1.   

Abstract

Ultrasound and photoacoustic imaging are highly complementary modalities since both use ultrasonic detection for operation. Increasingly, photoacoustic and ultrasound have been integrated in terms of hardware instrumentation. To generate a broadly accessible dual-modality contrast agent, we generated microbubbles (a standard ultrasound contrast agent) in a solution of methylene blue (a standard photoacoustic dye). This MB2 solution was formed effectively and was optimized as a dual-modality contrast solution. As microbubble concentration increased (with methylene blue concentration constant), photoacoustic signal was attenuated in the MB2 solution. When methylene blue concentration increased (with microbubble concentration held constant), no ultrasonic interference was observed. Using an MB2 solution that strongly attenuated all photoacoustic signal, high powered ultrasound could be used to burst the microbubbles and dramatically enhance photoacoustic contrast (>800-fold increase), providing a new method for spatiotemporal control of photoacoustic signal generation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390438     DOI: 10.1117/1.JBO.19.1.016005

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  31 in total

Review 1.  Molecular Photoacoustic Contrast Agents: Design Principles & Applications.

Authors:  Raymond E Borg; Jonathan Rochford
Journal:  Photochem Photobiol       Date:  2018-08-20       Impact factor: 3.421

Review 2.  Contrast-enhanced dual mode imaging: photoacoustic imaging plus more.

Authors:  Sungjo Park; Unsang Jung; Seunghyun Lee; Donghyun Lee; Chulhong Kim
Journal:  Biomed Eng Lett       Date:  2017-01-23

Review 3.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 4.  Opportunities for Photoacoustic-Guided Drug Delivery.

Authors:  Jun Xia; Chulhong Kim; Jonathan F Lovell
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

5.  Towards clinical photoacoustic and ultrasound imaging: Probe improvement and real-time graphical user interface.

Authors:  Jeesu Kim; Eun-Yeong Park; Byullee Park; Wonseok Choi; Ki J Lee; Chulhong Kim
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-09

Review 6.  Structural and functional photoacoustic molecular tomography aided by emerging contrast agents.

Authors:  Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2014       Impact factor: 54.564

7.  From Light to Sound: Photoacoustic and Ultrasound Imaging in Fundamental Research of Alzheimer's Disease.

Authors:  Yuqi Tang; Xuejun Qian; Darrin J Lee; Qifa Zhou; Junjie Yao
Journal:  OBM Neurobiol       Date:  2020-04-30

Review 8.  Advanced optoacoustic methods for multiscale imaging of in vivo dynamics.

Authors:  X L Deán-Ben; S Gottschalk; B Mc Larney; S Shoham; D Razansky
Journal:  Chem Soc Rev       Date:  2017-04-18       Impact factor: 54.564

9.  Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.

Authors:  Yanli Peng; Lianhua Zhu; Luofu Wang; Yu Liu; Kejing Fang; Minmin Lan; Daijia Shen; Deng Liu; Zhiping Yu; Yanli Guo
Journal:  Int J Nanomedicine       Date:  2019-11-26

10.  Pickering Bubbles as Dual-Modality Ultrasound and Photoacoustic Contrast Agents.

Authors:  Al de Leon; Peiran Wei; Filip Bordera; Dana Wegierak; Madelyn McMillen; David Yan; Christina Hemmingsen; Michael C Kolios; Emily B Pentzer; Agata A Exner
Journal:  ACS Appl Mater Interfaces       Date:  2020-05-01       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.